Benzinga | Dec 24, 2020 08:07AM EST

'Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial' - The Lancet

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30433-8/fulltext